Search results
Americans with HIV are living longer. Federal spending isn’t keeping up
Detroit News· 21 hours agoMalcolm Reid recently marked the anniversary of his HIV diagnosis on Facebook. “Diagnosed with HIV...
Philadelphia FIGHT’s HIV Education Summit will return for in-person June event
WHYY· 5 hours agoPhiladelphia FIGHT began as a grassroots advocacy group that championed the health rights of those...
Appeals court finds 'Obamacare' pillar unconstitutional in suit over HIV-prevention drug
NBC Universal via AOL· 2 days agoThe lawsuit centered on the objections of a coalition of small businesses in Texas to the...
Federal appeals court says some employers can exclude HIV prep from insurance coverage
WDTN-TV 2 Dayton· 2 days agoNEW ORLEANS (AP) — Employers who challenged some federal health insurance requirements cannot be...
Column: Anthony Fauci has a right to savage Trump. His memoir takes a different and telling approach
Los Angeles Times Opinion via Yahoo News· 10 hours agoAs director of the National Institute of Allergy and Infectious Diseases, he was at the red hot...
Community-based early HIV testing and treatment to manage and prevent emerging HIV among people who...
Medical Xpress· 6 days agoCommunity-based testing and treatment response to Glasgow's HIV outbreak among people who inject...
Gilead (GILD) Up as Twice-Yearly HIV Shot Prevents Infection
Zacks via Yahoo Finance· 2 days agoGilead's (GILD) twice-yearly, subcutaneous lenacapavir has demonstrated its potential as a new tool...
Old report about overseas Filipino workers with HIV falsely linked to Dubai
AFP via Yahoo News· 4 days agoA news report from 2011 about HIV infections among Philippine migrant workers has resurfaced in...
Co-discoverer of HIV to bring his research to USF. He’s looking for a cure.
Tampa Bay Times· 6 days agoRobert Gallo, 87, is still hunting for a cure to HIV. Gallo, an influential scientist who’s credited...
Gilead's HIV prevention trial shows promise with zero infections By Investing.com
Investing.com· 3 days agoGilead Sciences, Inc. (NASDAQ:GILD) has reported that its Phase 3 trial of an injectable HIV...